Towards Healthcare
Disposable Diabetes Lancets Market Size and Strategic Insights

Disposable Diabetes Lancets Market to Hit $1.9 Bn by 2034

Disposable diabetes lancets are sterile needles used for blood glucose monitoring, crucial for managing type I and II diabetes. The market is expanding due to the rise in diabetes prevalence and advancements like pain-free lancet devices. Recent trends include Roche's local manufacturing in India and MTD's acquisition of Ypsomed's business.

The disposable diabetes lancets market size was estimated at US$ 1.19 billion in 2023 and is projected to grow to US$ 1.9 billion by 2034, rising at a compound annual growth rate (CAGR) of 4.33% from 2024 to 2034. The increasing demand for point-of-care diagnostics, the rising prevalence of diabetes, and technological advancements drive the market.

Disposable Diabetes Lancets Market Revenue 2023 - 2034

Unlock Infinite Advantages: Subscribe to Annual Membership

Disposable Diabetes Lancets Market: Simplifying Diabetes Testing

Lancets are sterile, sharp needles used to withdraw a minuscule amount of blood sample by pricking the skin of the finger. They are generally disposable, i.e. used only once. They are of two types: standard lancets and safety lancets. They are widely used in monitoring blood glucose in diabetic patients. The increasing demand for point-of-care diagnostics for blood glucose monitoring promotes the use of lancets.

The rising prevalence of both type I ae II diabetes mellitus requires frequent monitoring of blood glucose levels. The demand for lancets increases with the advent of the latest technologies like lancet devices. Lancet devices are small tubes that launch a small needle without causing pain to the patient.

  • In May 2024, Roche Diabetes Care India announced the manufacturing of their glucose monitoring device, Accu-Chek Active, in India. The decision was made to improve access to diabetes care and meet the growing needs of the Indian market in collaboration with their manufacturing partner Sanmina-SCI India Pvt. Ltd. and assembly & distribution partner Parekh Integrated Services Pvt. Ltd.
  • In August 2024, Medical Technology and Devices (MTD) announced the acquisition of Ypsomed’s Pen Needles and Blood Glucose Monitoring Systems businesses. MTD is also implementing a substantial investment plan to establish production facilities for pen needles and lancets in Europe.
  • The National Health Service of the UK recommends checking blood sugar levels every 3 months when newly diagnosed and every 6 months once the condition is stable.

Latest Innovations: Opportunity for the Disposable Diabetes Lancets Market

The rising demand for disposable diabetes lancets drives the latest innovations to improve the device’s capability. The rising prevalence of diabetes and the demand for painless blood withdrawal result in novel lancet designs. Some devices use lancets with a small diameter to deliver painless pricking. Some manufacturers have designed vacuum-assisted lancing devices that use vacuum before, during, and after lancing to accelerate blood withdrawal. Some lancing devices have multiple depth settings to suit different skin settings. The fear of self-pricking in many individuals is lowered with such advancements. Lancing devices with retractable needles significantly reduces pain, the fear of self-pricking, and the chances of needlestick injuries. They also maintain the sterility of the lancets. Another advancement in lancet design is high-speed needle propulsion. The lancet can prick the skin as soon as it touches the skin’s surface.

Risk of Needlestick Injuries and Continuous Glucose Monitoring Hinder the Disposable Diabetes Lancets Market

The major challenge of using a disposable diabetes lancet is the risk of needlestick injuries. Needlestick injuries are caused due to accidentally pricking the skin with a used needle. This could lead to the transmission of diseases like HIV, hepatitis B, and hepatitis C. Another major challenge is the demand for continuous glucose monitoring using a wearable device. A wearable device can track changes in blood glucose levels in real time, eliminating the use of conventional blood glucose monitoring devices.

Regional Insights

Demand for Point-of-Care Diagnostics: North America to Sustain as a Leader

North America held a dominant presence in the disposable diabetes lancets market in 2023. The rising prevalence of diabetes, technological advancements, demand for point-of-care diagnostics, and the presence of key players drive the market. Diabetes in the US is a major public health concern affecting approximately 37.3 million Americans or 11.3% of the total population.

In Canada, approximately 4.1 million people were diagnosed with both type 1 and type 2 diabetes in 2023 and it is estimated to rise to 5.1 million by 2033. The market is also driven by favorable government policies to support point-of-care diagnostics. The National Institute of Biomedical Imaging and Bioengineering supports point-of-care technology development that provides real-time medical evaluation and analysis of the disease status or condition at the time and place of patient care. They also provide research funding for the novel development of the device.

Rising Prevalence of Diabetes: Asia to Grow Rapidly

Asia-Pacific is anticipated to grow with the highest CAGR in the disposable diabetes lancets market during the studied years. The rising geriatric population, increasing prevalence of diabetes, technological advancements, rapidly growing healthcare infrastructure, and increasing investments & collaborations drive the market. Countries like China, India, and Pakistan have the highest number of diabetes cases in the world. China is the leading country with more than 141 million people living with diabetes. According to a new study published in The Lancet, it is estimated that 101 million people in India are living with diabetes, i.e. around 11.4% of the country’s population. In 2023, The Ministry of Health and Family Welfare, India launched an initiative of screening and placing 75 million people with hypertension or diabetes on Standard Care by 2025.

Segmental Insights

By type, the safety lancets segment is estimated to gain traction in the disposable diabetes lancets market in the upcoming years. Safety lancets are a safer alternative to standard lancets as they do not have the risk of needlestick injuries. They can puncture and penetrate to a predetermined depth, hence they are personalized to every patient type. Technological advancements and the latest innovations augment the segment’s growth.

By application, the hospital & clinic segment held the largest share of the disposable diabetes lancets market in 2023. The increasing number of patients for diabetes testing and suitable facilities for disposing of lancets boost the segment’s growth. Disposable diabetes lancets are widely used in hospitals & clinics as they have trained professionals, thereby reducing the chance of injury or infection.

Recent Developments in the Disposable Diabetes Lancets Market

  • In April 2024, Drawbridge Health announced that they received 510(k) clearance from the US FDA for its advanced at-home blood sampling device, NanoDrop Lancet, for OTC use. NanoDrop Lancet is the US FDA-approved OTC blood-lancing device labeled for the upper arm.
  • In March 2023, Pip Diabetes developed painless, single-use lancets to help customers get a clean and painless blood sample. The lancets are precision-engineered to ensure proper needle gauge and depth and to minimize vibration, eliminating pain from the fingerstick.

Top Companies in the Disposable Diabetes Lancets Market

  • A. Menarini Diagnostics
  • Acon Diabetes Care
  • AdvaCare Pharma
  • Arkray Healthcare Pvt. Ltd.
  • BioCare Corporation
  • CVS Pharmacy
  • Drawbridge Health
  • Genteel
  • Hoffman La-Roche Ltd.
  • Owen Mumford
  • Pip Diabetes
  • SD Biosensor Healthcare Pvt. Ltd.

Segments Covered in the Report

By Type

  • Safety Lancets
  • Ordinary Lancets

By Application

  • Hospital & Clinic
  • Family
  • Others

By Region

  • North America
    • US
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Thailand
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • UAE
    • Saudi Arabia
    • Kuwait
  • Insight Code: 5318
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: November 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

A blood lancet is a specialized type of needle that is similar to a scalpel-style lancet but with a double-edged blade and a pointed end.

The middle or ring finger is preferred for pricking the skin to withdraw blood as they have the greatest depth of tissue beneath the skin and hence offers the least chances of injury.

National Health Service, World Health Organization, Food and Drug Administration, International Diabetes Federation.